Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-062484
Filing Date
2021-05-06
Accepted
2021-05-06 17:02:20
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 tm2114742-1_s3.htm S-3 260229
2 EXHIBIT 5.1 tm2114742d2_ex5-1.htm EX-5.1 31897
3 EXHIBIT 23.1 tm2114742d2_ex23-1.htm EX-23.1 2183
4 EXHIBIT 23.2 tm2114742d2_ex23-2.htm EX-23.2 3351
5 GRAPHIC lg_vynethera-4c.jpg GRAPHIC 481141
  Complete submission text file 0001104659-21-062484.txt   954376
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-255841 | Film No.: 21898789
SIC: 2834 Pharmaceutical Preparations